-
Mashup Score: 1Login - Integrity CE - 9 hour(s) ago
Username* Password* Remember me Register | Forgot Password
Source: integrityce.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51FDA Approves Dato-DXd in HR+/HER2– Breast Cancer - 6 day(s) ago
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for patients with HR-positive, HER2-negative breast cancer.
Source: www.targetedonc.comCategories: General Medicine News, Hem/OncsTweet-
🚨Kicking off 2025 with a new approval from @FDAOncology FDA Approves Dato-DXd in HR+/HER2– Breast Cancer https://t.co/1I9MX66Pcv via @targetedonc @OncoAlert
-
-
Mashup Score: 49FDA Approves Dato-DXd in HR+/HER2– Breast Cancer - 7 day(s) ago
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for patients with HR-positive, HER2-negative breast cancer.
Source: www.targetedonc.comCategories: General Medicine News, Hem/OncsTweet-
🚨Kicking off 2025 with a new approval from @FDAOncology FDA Approves Dato-DXd in HR+/HER2– Breast Cancer https://t.co/1I9MX66Pcv via @targetedonc @OncoAlert
-
-
Mashup Score: 0
Welcome! You are invited to join a meeting: Solutions for Success: Enhancing Patient Access and Accrual in Cancer Clinical Trials. After registering, you will receive a confirmation email about joining the meeting.
Source: zoom.usCategories: General Medicine News, Hem/OncsTweet-
Join me for the @AmericanCancer NBCRT Clinical Trials Webinar: "Solutions for Success: Enhancing Patient Access and Accrual in Cancer Clinical Trials" January 23, 2025, at 2:00 PM ET Â Register here: https://t.co/PLc5FSAMss #ACSNBCRT #ClinicalTrials #HealthEquity #bcsm https://t.co/BUY1sWhkca
-
-
Mashup Score: 10I'm supporting Dempsey Center! - 26 day(s) ago
Making life better for people managing the impact of cancer
Source: support.dempseycenter.orgCategories: General Medicine News, Hem/OncsTweet-
Day 3 #NewYearResolutions, goals & values #Volunteer #Give I am proud to volunteer, donate and/or fundraise for organizations like The Dempsey Center https://t.co/v1XFDsTAdM as well as @AmericanCancer @ConquerCancerFd @HCWvsHunger and more! âť“What orgs will/do you support?
-
-
Mashup Score: 4Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer - 1 month(s) ago
This randomized clinical trial assesses whether the omission of sentinel node biopsy is noninferior to sentinel lymph node biopsy in female patients with small breast cancer and negative results on preoperative ultrasonography of axillary lymph nodes.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
@OncBrothers @DrHBurstein @JenniferPlichta We are following the #SOUND trial inclusion rigorously. It seems early to color outside the lines, but this is a good step towards right-sized care. Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer https://t.co/v8mGRDTlfj
-
-
Mashup Score: 14
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
“Nailing down” risk and improving outcomes in early-stage breast cancer https://t.co/kjDTkyIQTz @coffeemommy @KalinskyKevin @OncoAlert https://t.co/UE6xJ16YVf
-
-
Mashup Score: 14
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
“Nailing down” risk and improving outcomes in early-stage breast cancer https://t.co/kjDTkyIQTz @coffeemommy @KalinskyKevin @OncoAlert https://t.co/UE6xJ16YVf
-
-
Mashup Score: 14
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
“Nailing down” risk and improving outcomes in early-stage breast cancer https://t.co/kjDTkyIQTz @coffeemommy @KalinskyKevin @OncoAlert https://t.co/UE6xJ16YVf
-
-
Mashup Score: 14
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
“Nailing down” risk and improving outcomes in early-stage breast cancer https://t.co/kjDTkyIQTz @coffeemommy @KalinskyKevin @OncoAlert https://t.co/UE6xJ16YVf
-
RT @SoMeCME: 6/ We hope you enjoyed this #BRCAbrief! Complete the posttest & evaluation here 👉 https://t.co/oZu3a6OCjM & claim your 🆓 CME!…